Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

While some GLP-1s are approved for patients age 12 and older, only a few telehealth companies will prescribe them to children.

BEN Shephard awkwardly stepped in on today’s This Morning when former politician Nadine Dorries repeatedly plugged a ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

Nearly 16% of American adults -- that's close to 1 in 6 -- now has diabetes, according to the latest data from the U.S.

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Experiencing excessive daytime sleepiness as an older adult can spell dire consequences that ultimately may lead to ...

GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams ...

New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

In a Q&A, an FDA spokesperson discusses efforts to reduce misinformation about biosimilars through education, the agency’s ...

Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...